PT Sarana Meditama Metropolitan Tbk (IDX:SAME)
408.00
+8.00 (2.00%)
At close: Dec 5, 2025
IDX:SAME Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 1,792,360 | 1,706,381 | 1,531,660 | 1,393,542 | 1,271,584 | 816,816 | Upgrade
|
| Revenue Growth (YoY) | 6.31% | 11.41% | 9.91% | 9.59% | 55.68% | 54.31% | Upgrade
|
| Cost of Revenue | 1,264,762 | 1,203,868 | 1,090,038 | 950,231 | 752,905 | 547,134 | Upgrade
|
| Gross Profit | 527,598 | 502,513 | 441,623 | 443,311 | 518,679 | 269,682 | Upgrade
|
| Selling, General & Admin | 407,746 | 410,004 | 405,122 | 413,715 | 325,966 | 290,287 | Upgrade
|
| Other Operating Expenses | -8,429 | -9,703 | -10,452 | -4,581 | -4,450 | -6,586 | Upgrade
|
| Operating Expenses | 399,317 | 400,301 | 394,670 | 409,134 | 321,516 | 283,702 | Upgrade
|
| Operating Income | 128,281 | 102,212 | 46,952 | 34,177 | 197,163 | -14,020 | Upgrade
|
| Interest Expense | -72,438 | -79,160 | -69,778 | -40,388 | -41,094 | -114,640 | Upgrade
|
| Interest & Investment Income | 2,304 | 4,138 | 6,026 | 6,797 | 12,719 | 933.99 | Upgrade
|
| Earnings From Equity Investments | 25,459 | 17,492 | 35,640 | 22,356 | -11,594 | 71,583 | Upgrade
|
| Other Non Operating Income (Expenses) | -7,182 | -6,730 | -6,207 | -5,826 | - | - | Upgrade
|
| EBT Excluding Unusual Items | 76,424 | 37,952 | 12,633 | 17,117 | 157,195 | -56,143 | Upgrade
|
| Gain (Loss) on Sale of Assets | 515.97 | 216.57 | 374.56 | 107.79 | -13,038 | 833.39 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -20,300 | Upgrade
|
| Pretax Income | 76,940 | 38,169 | 13,007 | 17,225 | 144,157 | -75,610 | Upgrade
|
| Income Tax Expense | 21,113 | 17,564 | -4,735 | 7,642 | 1,520 | 112,035 | Upgrade
|
| Earnings From Continuing Operations | 55,827 | 20,605 | 17,742 | 9,583 | 142,637 | -187,644 | Upgrade
|
| Minority Interest in Earnings | -7,657 | -8,757 | -5,490 | -5,235 | 1,533 | 1.35 | Upgrade
|
| Net Income | 48,170 | 11,849 | 12,252 | 4,347 | 144,169 | -187,643 | Upgrade
|
| Net Income to Common | 48,170 | 11,849 | 12,252 | 4,347 | 144,169 | -187,643 | Upgrade
|
| Net Income Growth | - | -3.29% | 181.84% | -96.98% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 17,155 | 17,147 | 17,137 | 17,130 | 13,544 | 6,671 | Upgrade
|
| Shares Outstanding (Diluted) | 17,155 | 17,147 | 17,137 | 17,130 | 13,544 | 6,671 | Upgrade
|
| Shares Change (YoY) | 0.07% | 0.06% | 0.04% | 26.48% | 103.02% | 13.07% | Upgrade
|
| EPS (Basic) | 2.81 | 0.69 | 0.71 | 0.25 | 10.64 | -28.13 | Upgrade
|
| EPS (Diluted) | 2.81 | 0.69 | 0.71 | 0.25 | 10.64 | -28.13 | Upgrade
|
| EPS Growth | - | -3.35% | 181.73% | -97.62% | - | - | Upgrade
|
| Free Cash Flow | -28,101 | -490.41 | -320,773 | -4,784 | 114,699 | -109,452 | Upgrade
|
| Free Cash Flow Per Share | -1.64 | -0.03 | -18.72 | -0.28 | 8.47 | -16.41 | Upgrade
|
| Gross Margin | 29.44% | 29.45% | 28.83% | 31.81% | 40.79% | 33.02% | Upgrade
|
| Operating Margin | 7.16% | 5.99% | 3.06% | 2.45% | 15.50% | -1.72% | Upgrade
|
| Profit Margin | 2.69% | 0.69% | 0.80% | 0.31% | 11.34% | -22.97% | Upgrade
|
| Free Cash Flow Margin | -1.57% | -0.03% | -20.94% | -0.34% | 9.02% | -13.40% | Upgrade
|
| EBITDA | 339,833 | 314,505 | 267,457 | 237,416 | 346,941 | 78,960 | Upgrade
|
| EBITDA Margin | 18.96% | 18.43% | 17.46% | 17.04% | 27.28% | 9.67% | Upgrade
|
| D&A For EBITDA | 211,552 | 212,293 | 220,504 | 203,239 | 149,778 | 92,980 | Upgrade
|
| EBIT | 128,281 | 102,212 | 46,952 | 34,177 | 197,163 | -14,020 | Upgrade
|
| EBIT Margin | 7.16% | 5.99% | 3.06% | 2.45% | 15.50% | -1.72% | Upgrade
|
| Effective Tax Rate | 27.44% | 46.02% | - | 44.37% | 1.05% | - | Upgrade
|
| Advertising Expenses | - | - | - | 15,284 | 7,373 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.